THERILLUME Trademark

Trademark Overview

On Thursday, June 3, 2021, a trademark application was filed for THERILLUME with the United States Patent and Trademark Office. The USPTO has given the THERILLUME trademark a serial number of 90751726. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Tuesday, February 13, 2024. This trademark is owned by Recombinetics, Inc.. The THERILLUME trademark is filed in the Advertising, Business and Retail Services category with the following description:

Commercialization services in the field of oncology therapeutics, namely, business consultancy services, market research, and marketing consulting services, marketing services, and sales management
therillume

General Information

Serial Number90751726
Word MarkTHERILLUME
Filing DateThursday, June 3, 2021
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateTuesday, February 13, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 7, 2022

Trademark Statements

Goods and ServicesCommercialization services in the field of oncology therapeutics, namely, business consultancy services, market research, and marketing consulting services, marketing services, and sales management

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, May 2, 2022
Primary Code035
First Use Anywhere DateMonday, December 27, 2021
First Use In Commerce DateMonday, December 27, 2021

Trademark Owner History

Party NameRecombinetics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressEagan, MN 55121
Party NameRecombinetics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSt. Paul, MN 55104

Trademark Events

Event DateEvent Description
Friday, February 16, 2024ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Wednesday, February 14, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, February 13, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, January 30, 2024STATEMENT OF USE PROCESSING COMPLETE
Wednesday, January 10, 2024USE AMENDMENT FILED
Tuesday, January 30, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, January 10, 2024TEAS STATEMENT OF USE RECEIVED
Friday, August 4, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 2, 2023SOU EXTENSION 2 GRANTED
Wednesday, August 2, 2023SOU EXTENSION 2 FILED
Wednesday, August 2, 2023SOU TEAS EXTENSION RECEIVED
Saturday, February 4, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 2, 2023SOU EXTENSION 1 GRANTED
Thursday, February 2, 2023SOU EXTENSION 1 FILED
Thursday, February 2, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, August 2, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 7, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 7, 2022PUBLISHED FOR OPPOSITION
Wednesday, May 18, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, May 5, 2022LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, May 4, 2022ASSIGNED TO LIE
Monday, May 2, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, May 2, 2022EXAMINER'S AMENDMENT ENTERED
Monday, May 2, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, May 2, 2022EXAMINERS AMENDMENT E-MAILED
Monday, May 2, 2022EXAMINERS AMENDMENT -WRITTEN
Monday, April 25, 2022PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, November 30, 2021WITHDRAWN FROM PUB - OG REVIEW QUERY
Monday, November 15, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 15, 2021EXAMINER'S AMENDMENT ENTERED
Monday, November 15, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, November 15, 2021EXAMINERS AMENDMENT E-MAILED
Monday, November 15, 2021EXAMINERS AMENDMENT -WRITTEN
Friday, November 12, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 11, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 11, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, October 16, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, October 16, 2021NON-FINAL ACTION E-MAILED
Saturday, October 16, 2021NON-FINAL ACTION WRITTEN
Saturday, October 16, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, October 16, 2021NON-FINAL ACTION E-MAILED
Saturday, October 16, 2021NON-FINAL ACTION WRITTEN
Thursday, September 23, 2021ASSIGNED TO EXAMINER
Thursday, August 26, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 7, 2021NEW APPLICATION ENTERED

Related Keywords

therillume services marketing research consulting sales management market business oncology field